Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Fractyl Health (GUTS) Cost of Revenue (2023 - 2024)

Fractyl Health's Cost of Revenue history spans 2 years, with the latest figure at $7000.0 for Q3 2024.

  • For the quarter ending Q3 2024, Cost of Revenue fell 72.0% year-over-year to $7000.0, compared with a TTM value of $50000.0 through Dec 2024, down 35.06%, and an annual FY2024 reading of $50000.0, down 35.06% over the prior year.
  • Cost of Revenue for Q3 2024 was $7000.0 at Fractyl Health, down from $24000.0 in the prior quarter.
  • The five-year high for Cost of Revenue was $47000.0 in Q2 2023, with the low at $2000.0 in Q4 2023.